INS and type 1 diabetes mellitus: Similar results were obtained for circulating insulin levels: serum insulin levels were significantly elevated by 90% in T1DM mice treated with empagliflozin (3mg/kg) compared with the vehicle group (Fig 2B; vehicle 1.00±0.12 vs empagliflozin 1.90±0.43).